2007
DOI: 10.1016/j.applanim.2006.11.007
|View full text |Cite
|
Sign up to set email alerts
|

Canine cognitive dysfunction syndrome: Prevalence, clinical signs and treatment with a neuroprotective nutraceutical

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

5
72
1
10

Year Published

2014
2014
2024
2024

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 101 publications
(102 citation statements)
references
References 79 publications
5
72
1
10
Order By: Relevance
“…In some primates that have suffered from cognitive dysfunction, low levels of norepinephrine have also been found (Osella et al 2005). Both these catecholamines and the serotoninergic system are affected.…”
Section: Physiopathology Of Cognitive Dysfunction Syndrome In Dogsmentioning
confidence: 97%
See 4 more Smart Citations
“…In some primates that have suffered from cognitive dysfunction, low levels of norepinephrine have also been found (Osella et al 2005). Both these catecholamines and the serotoninergic system are affected.…”
Section: Physiopathology Of Cognitive Dysfunction Syndrome In Dogsmentioning
confidence: 97%
“…Its prevalence has not been established in many countries of Europe or America, but a poll taken by 981 owners of dogs older than 7 years in the United Kingdom suggested that approximately one-third of the dogs showed signs of confusion, restlessness and less enjoyment of life, while 1 out of 5 showed an increase in the incidence of habitual hygiene problems (Heath et al 2007). A study conducted in Italy that included 124 geriatric dogs showed a CDS prevalence of nearly 50%, in which 75 dogs over 7 years old showed signs that correlated with the disease (Osella et al 2007). An American study included 97 bitches and 83 castrated dogs, all between the ages of 11 and 16.…”
Section: Epidemiology Of Coginitive Dysfunction Syndrome In Dogsmentioning
confidence: 99%
See 3 more Smart Citations